生物阻抗分析指导的容量扩张预防造影剂急性肾损伤:BELIEVE 先导随机对照试验
BELIEVE 先导随机对照试验纳入 61 例择期心脏造影的慢性肾脏病患者,比较生物阻抗分析(BIA)指导的个体化等渗碳酸氢钠水化与标准化方案。BIA 指导水化安全,CI-AKI 发生率可能更低但未达统计学显著。
要点
- BIA 指导的等渗碳酸氢钠水化在轻中度肾功能不全患者中安全。
- BIA 组输液量显著多于标准方案,CI-AKI 发生率数值上更低但无统计学差异。
- 该研究为小样本先导试验,结果需更大规模研究验证。
核心结论
- 在轻中度肾功能不全患者中,BIA 指导的等渗碳酸氢钠水化安全,CI-AKI 发生率可能更低但未达统计学显著。
研究设计与样本
- 先导性、随机、平行组、单盲、对照试验,纳入 61 例择期心脏造影的慢性肾脏病患者,BIA 组 30 例,对照组 31 例。
主要发现
- CI-AKI 发生率 BIA 组 3.3%,对照组 6.5%(RR=0.52,95%CI 0.05-5.40,P=1.00)。
- 不良事件发生率两组相当(6.7% vs 6.5%,P=1.00)。
关键数值与推荐
- CI-AKI 定义为心脏造影后 48-72 小时内血清肌酐升高≥0.3 mg/dl 或≥150%。
- BIA 指导方案根据细胞外水与总体水比值(ECW/TBW)调整等渗碳酸氢钠输液。
临床怎么用
- 对择期心脏造影的慢性肾脏病患者,可考虑用 BIA 评估容量状态以个体化水化,但需注意证据来自小样本先导试验。
局限性
- 样本量小(61 例),CI-AKI 事件数少,统计效能不足。
- 为单中心先导试验,结论需更大规模研究证实。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Peri-procedural i.v. fluid administration is important for the prevention of contrast-induced acute kidney injury (CI-AKI). However, standardized fluid management protocols may not be suitable for all patients. We therefore wished to determine whether an individualized fluid administration protocol guided by measuring extracellular water (ECW) using bioimpedance analysis (BIA) would be safe and would reduce the incidence CI-AKI compared to a standardized fluid administration prescription. METHODS: In this pilot, randomized, parallel-group, single-blind, controlled trial, we compared the effect of BIA-guided isotonic bicarbonate administration according to the ratio of ECW to total body water (ECW/TBW) to our standard isotonic bicarbonate protocol in regard to the safety and efficacy of preventing CI-AKI in chronic kidney disease patients undergoing elective cardiac angiography. Our primary outcome was the incidence of CI-AKI, which was defined as a ≥0.3 mg/dl or 150% increase in serum creatinine concentration within 48 to 72 hours after cardiac angiography. RESULTS: We studied 61 patients, 30 in the bioimpedance group and 31 in the control group. Age was similar (72.5 ± 7 vs. 71.4 ± 7.9 years), as were body mass index (25.5 vs. 25.8 kg/m2) and baseline serum creatinine (1.3 ± 0.3 vs. 1.4 ± 0.4 mg/dl). The peri-procedural fluid volume administered was significantly greater in the BIA-guided hydration group (899.0 ± 252.7 ml vs. 594.4 ± 125.9 ml, P < .01). The incidence of CI-AKI was 3.3% in BIA-guided hydration group and 6.5% in the control group (relative risk = 0.52, 95% confidence interval = 0.05-5.40, P = 1.00). Adverse events reported were comparable between groups (6.7% vs. 6.5%, P = 1.00). CONCLUSIONS: The overall incidence of CI-AKI after cardiac angiography in our patients with mild-to-moderate renal insufficiency was lower than anticipated. Isotonic bicarbonate administration guided by bioimpedance measurements was safe, and probably led to a lower incidence of CI-AKI, although this not reach statistical significance.
引用
- Kananuraks S, Assanatham M, Boongird S, et al. Bioimpedance Analysis-Guided Volume Expansion for the Prevention of Contrast-Induced Acute Kidney Injury (the BELIEVE Pilot Randomized Controlled Trial). Kidney Int Rep. 2020. PMID: 32954073. doi:10.1016/j.ekir.2020.07.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。